IL37 and rheumatoid arthritis: Research demonstrates that IL-37 reduces TNF-α and IL-1β cytokine production from human macrophages, is increased in chronic heart failure patients and attenuated the production of inflammatory cytokines in serum or synovial joints in RA, suggesting IL-37 may have a role in clinical disease (274–276).